USPP27475P2 - Cannabis plant named ‘Ecuadorian Sativa’ - Google Patents
Cannabis plant named ‘Ecuadorian Sativa’ Download PDFInfo
- Publication number
- USPP27475P2 USPP27475P2 US12/661,271 US66127110V USPP27475P2 US PP27475 P2 USPP27475 P2 US PP27475P2 US 66127110 V US66127110 V US 66127110V US PP27475 P2 USPP27475 P2 US PP27475P2
- Authority
- US
- United States
- Prior art keywords
- sativa
- cannabis
- ssp
- plant
- indica
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 241000218236 Cannabis Species 0.000 title claims 2
- 241000196324 Embryophyta Species 0.000 claims abstract description 39
- 244000025254 Cannabis sativa Species 0.000 abstract description 16
- 235000008697 Cannabis sativa Nutrition 0.000 abstract description 11
- 244000265144 hemp Species 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 230000000762 glandular Effects 0.000 abstract description 5
- 241000894007 species Species 0.000 abstract description 5
- 210000004209 hair Anatomy 0.000 abstract description 4
- 206010024264 Lethargy Diseases 0.000 abstract description 3
- 230000001077 hypotensive effect Effects 0.000 abstract description 3
- 230000002673 intoxicating effect Effects 0.000 abstract description 3
- 239000000835 fiber Substances 0.000 abstract description 2
- 231100000567 intoxicating Toxicity 0.000 abstract description 2
- 244000273618 Sphenoclea zeylanica Species 0.000 abstract 1
- 240000004308 marijuana Species 0.000 description 17
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 16
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 14
- 238000005520 cutting process Methods 0.000 description 11
- SEEZIOZEUUMJME-FOWTUZBSSA-N cannabigerolic acid Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-FOWTUZBSSA-N 0.000 description 10
- SEEZIOZEUUMJME-VBKFSLOCSA-N Cannabigerolic acid Natural products CCCCCC1=CC(O)=C(C\C=C(\C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-VBKFSLOCSA-N 0.000 description 9
- SEEZIOZEUUMJME-UHFFFAOYSA-N cannabinerolic acid Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-UHFFFAOYSA-N 0.000 description 9
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 7
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 description 7
- 229930003827 cannabinoid Natural products 0.000 description 7
- 239000003557 cannabinoid Substances 0.000 description 7
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 7
- 229960004242 dronabinol Drugs 0.000 description 7
- 235000001510 limonene Nutrition 0.000 description 7
- 229940087305 limonene Drugs 0.000 description 7
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 6
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 6
- UCONUSSAWGCZMV-HZPDHXFCSA-N Delta(9)-tetrahydrocannabinolic acid Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCCCC)C(C(O)=O)=C1O UCONUSSAWGCZMV-HZPDHXFCSA-N 0.000 description 5
- QXACEHWTBCFNSA-UHFFFAOYSA-N cannabigerol Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-UHFFFAOYSA-N 0.000 description 5
- 230000009897 systematic effect Effects 0.000 description 5
- 150000003505 terpenes Chemical class 0.000 description 5
- 235000007586 terpenes Nutrition 0.000 description 5
- 241000266847 Mephitidae Species 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 3
- UVOLYTDXHDXWJU-UHFFFAOYSA-N Cannabichromene Chemical compound C1=CC(C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-UHFFFAOYSA-N 0.000 description 3
- UVOLYTDXHDXWJU-NRFANRHFSA-N Cannabichromene Natural products C1=C[C@](C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-NRFANRHFSA-N 0.000 description 3
- 241000218231 Moraceae Species 0.000 description 3
- 241000218215 Urticaceae Species 0.000 description 3
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 3
- HRHJHXJQMNWQTF-UHFFFAOYSA-N cannabichromenic acid Chemical compound O1C(C)(CCC=C(C)C)C=CC2=C1C=C(CCCCC)C(C(O)=O)=C2O HRHJHXJQMNWQTF-UHFFFAOYSA-N 0.000 description 3
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 210000001672 ovary Anatomy 0.000 description 3
- 235000017807 phytochemicals Nutrition 0.000 description 3
- 229930000223 plant secondary metabolite Natural products 0.000 description 3
- 239000012882 rooting medium Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- -1 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl- Chemical group 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- 241000218235 Cannabaceae Species 0.000 description 2
- 241001573881 Corolla Species 0.000 description 2
- 241000006479 Cyme Species 0.000 description 2
- ORKZJYDOERTGKY-UHFFFAOYSA-N Dihydrocannabichromen Natural products C1CC(C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 ORKZJYDOERTGKY-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 244000170475 Saraca indica Species 0.000 description 2
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 2
- 229950011318 cannabidiol Drugs 0.000 description 2
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 description 2
- 235000005607 chanvre indien Nutrition 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000010413 gardening Methods 0.000 description 2
- 239000003630 growth substance Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 241000644351 Carolus Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 241000614260 Citrus macrosperma Species 0.000 description 1
- 240000007235 Cyanthillium patulum Species 0.000 description 1
- 241000218228 Humulus Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 235000013267 Pinus ponderosa Nutrition 0.000 description 1
- 241000555277 Pinus ponderosa Species 0.000 description 1
- 241000220221 Rosales Species 0.000 description 1
- 102000011842 Serrate-Jagged Proteins Human genes 0.000 description 1
- 108010036039 Serrate-Jagged Proteins Proteins 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000218220 Ulmaceae Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000011681 asexual reproduction Effects 0.000 description 1
- 238000013465 asexual reproduction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 244000213578 camo Species 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940065144 cannabinoids Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000003501 hydroponics Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 231100000568 intoxicate Toxicity 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000011490 mineral wool Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000013138 pruning Methods 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
- A01H5/12—Leaves
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
- A01H6/28—Cannabaceae, e.g. cannabis
Definitions
- This invention relates to a novel hybrid of a cross between individuals thought to be of the two subspecies of ‘ Cannabis sativa L.’, ‘ Cannabis sativa ; ssp. sativa ’ and ‘ Cannabis sativa ssp. Indica’.
- Cannabis indica Lam. was formally named somewhat later (de Lamarck, J B, 1(2) ENCYCLOPEDIE METHODIQUE DE BOTANIQUE, 694-5,(1785)), but is still very old in botanical history.
- Cannabis has been variously ascribed as belonging to the mulberry family (Moraceae) (Engler, H G A, Ulmaceae, Moraceae and Urticaceae, pages 59-118 (1889) in: A. Engler and K. Prantl eds., DIE NATURLICHEN PFLANZENFAMILIEN 3(1). W. Engelmann, Leipzig, Germany; Judd, W S, Sanders, R W, and Donoghue, M J, 5 HARVARD PAPERS IN BOTANY 5: 1-51 (1994)); nettle family
- the objective of the breeding program which produced the novel plant of this invention was primarily to develop a plant having the following characteristics: (a) medicinal properties that included hypotensive activity; (b) psychoactive properties that motivated and energized, rather than creating lethargy, sleepiness, and increased food consumption.
- THC tetrahydrocannabinol
- THC-A tetrahydrocannabinolic acid
- THC-A (6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6h-benzochromene-2-carboxylic acid
- CBG Cannabigerol
- Resorcinol 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-
- is not considered psychoactive is known to block the psychoactive effects of THC. and is considered medically active in a variety of conditions.
- cannabigerolic acid CBG-A, (E)-3-(3,7-Dimethyl-2,6-octadienyl)-2,4-dihydroxy-6-pentylbenzoic acid
- Cannabichromene, CBC, and cannabidiol, CBD are both non-psychoactive and end products of CBG metaolism, like THC, that are used medically Cannabichromenic acid
- CBC-A 5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-7-pentyl-chromene-6-carboxylic acid, is acidic cannabichromene.
- Equadorian Sativa has been shown by laboratory testing by Steephill Labs to contain cannabinoid CBG-A at 2.49 mg/g, tetrahydrocannibidiol THC-A at 139.46 mg/g, THC at 2.24 mg/g and cannabinoid CBC-A at 1.75 mg/g.
- Equadorian Sativa cannabinoid content is dominated by its high content of THC (2.24 mg/g) and THC-A (139.46 mg/g).
- Most varieties of high potency cannabis contain large quantities of three specific terpenes as well as various assortments of others. Those three terpenes are Beta-Myrcene, Beta Caryophyllene and Linalool.
- the variety CT3 has a profile with a high level of Beta-Myrcene, a moderate amount of Beta Caryophyllene and a small amount of Linalool, and a moderate amount of Limonene.
- ‘ Equadorian Sativa ’ has an unusual complement of terpenes. There are small levels of Beta Myrcene, Beta Caryophyllene and Linalool, but the Limonene level is extraordinarily high at a level of 4.53, 10 to 20 times the usual range. This sets ‘ Equadorian Sativa ’ apart from other varieties in its odor, the effects on mood and mentation and its medical qualities.
- Equadorian Sativa has many medical qualities that make it an important tool to maintain health and deal with illness.
- the inventor cultivated various strains of ‘ Cannabis sativa ’ in an effort to create a strain best suited to control his own disorder.
- This plant was derived from a female said to be of a strain called colloquially, ‘Celestial Temple Sativa’ an individual grown in Ecuador that reached a height of 23 ft (7 m), and was of the typical subspecies, ‘ Cannabis sativa ssp. sativa ’.
- the male parent is said to have been of a strain known colloquially as ‘island sweet skunk’ and reportedly to belonged to the subspecies ‘ Cannabis sativa ssp. indica (Lam.)’. Small and Cronquist 1976 Supra.
- ‘Celestial Temple Sativa’ nor ‘island sweet skunk’ has been patented in the United States or elsewhere, nor are they the subject of any pending patent applications of which the inventor is aware.
- the particular plant disclosed herein was discovered in the area where the inventor was intentionally cross-pollinating and cultivating plants of cross between ‘Celestial Temple Sativa’ and ‘island sweet skunk’ described above using standard Mendelian breeding procedures well known to those of ordinary skill in the art. This resulted in the F1 generation of the inventor's cross, named ‘Pleadian’. It was in the proximity of plants of the ‘Pleadian’ variety that had become hermaphroditic, in the inventor's garden in Lake Tahoe Calif. that he discovered one female plant that could only be reproduced assexually, by taking cuttings and that plant is the origin of this remarkable new strain. The female plant was discovered in a section of the inventor's hydroponic garden. The plant has been and continues to be assexually reproduced by cutting at the inventor's garden in Lake Tahoe Calif.
- Equadorian sativa was shown to have substantially lower levels of cannabigerolic acid (CBG-A). cannabigerol (CBG) and Beta-Myrcene.
- CBG-A cannabigerolic acid
- CBG cannabigerol
- Beta-Myrcene cannabigerol
- ‘ Equadorian sativa ’ had levels of only 2.49 mg/g of CBG-A while CTK had 6.1 mg/g CBG-A and CT3 had 8.13 mg/g of CBG-A.
- Equadorian sativa ’ had only 0.001 mg/g of CBG while CTK had 0.3 mg/g CBG and CT3 had 0.54 mg/g of CBG.
- Equadorian sativa ’ had only 1.1 mg/g Beta-Myrcene while CTK had 12.01 mg/g Beta-Myrcene and CT3 had 11.44 mg/g Beta-Myrcene.
- Asexual reproduction, colloqually known as “cloning” is a process well known to those of ordinary skill in the art of gardening and includes the following steps:
- Step 1 From the female plant whose genetic profile is sought to be exactly reproduced, a 1′′- 2′′ cutting is taken;
- Step 2 The cutting of the desired plant and is placed in a rooting solution that may be water, or a B1 vitamin that is generally the content of a rooting or cloning powder or gel;
- Step 3 The cutting and rooting solution are placed into a rooting medium such as rock wool and RAPID ROOTER® a peat moss product available at hydroponics stores, gardening supply stores, and from many Internet merchants and must be water retaining so that the roots can take water up into the leaves;
- Step 4 The cutting in rooting solution and rooting medium is placed under a humidity dome that may be an inverted plastic cup or is available in kits 1′-2′ long with a clear plastic dome to keep the humidity as high as possible to avoid the leaves drying before the cutting roots to insure viability;
- Step 5 A a fluorescent light is placed just over the humidity dome that may be a generic work light available at hardware stores;
- Step 6 One to two times a day, the humidity dome is removed for 30 seconds to insure the exchange of depleted air with fresh air to replenish the CO2.
- Step 7 After maintaining this cutting in this manner, keeping the rooting medium wet at all times, for 5-14 days until root formation
- Step 8 The rooted plants are maintained under flourescent high intensity lights in a soil-less medium, with standard hydroponic fertilizers, for 14 weeks; The plant observed and identified in the photographs was cultivated in this manner at a temperature between 76 and 80 degrees Fahrenheit and was 14 weeks of age. The new plant differs from its parents and related cultivars in that it has energizing and motivating psychoactive effects as opposed to the lethargy normally associated with ssp. indica and the instant plant also shows hypotensive effects.
- Sheet 1 ‘Cannabis CTS-A’ shows the flower of the ‘ Equadorian sativa ’ plant in the midst of leaves from above.
- Sheet 3 ‘Cannabis CTS-A’ comprises a slightly oblique and very close view of the ‘ Equadorian sativa’.
Abstract
Unique herbaceous annual ‘Cannabis sativa’ female plants, having numerous glandular flowers in a congested and elongated inflorescence, hollow stems a characteristic of the fiber-producing strains of ‘Cannabis sativa ssp. sativa’ but absent in strains of ‘Cannabis sativa ssp. indica.’ The plants are intoxicating, characteristic of ‘Cannabis sativa, ssp. indica’, but absent in subspecies sativa. The new strain has energizing and motivating psychoactive effects as opposed to the lethargy normally associated with ssp. indica and show hypotensive effects. Morphologically, the plants have a few branched hairs on the stem that are not characteristic of the species, but are ordinary in most other respects.
Description
The Cannabis plant named ‘Ecuadorian Sativa’ having a laboratory name of ‘CTS-A’ a variety of a cross between ‘Cannabis sativa; ssp. Sativa’ and ‘Cannabis sativa ssp. Indica (Lam.)’.
This invention relates to a novel hybrid of a cross between individuals thought to be of the two subspecies of ‘Cannabis sativa L.’, ‘Cannabis sativa; ssp. sativa’ and ‘Cannabis sativa ssp. Indica’.
Human cultivation history of Cannabis dates back 8000 years. Schultes, R E. 1970. Random thoughts and queries on the botany of Cannabis. Pages 11-38 in: CRB Joyce, and SH Curry eds., THE BOTANY AND CHEMISTRY OF CANNABIS. J. & A. Churchill. London, England. Hemp cloth recovered in Europe dates back 6000 years. (Small, E, Beckstead, H D, and Chan, A, 29(3) ECONOMIC BOTANY 29(3): 219-232 (1975). The written record of the pharmacologic properties of Cannabis goes back more than 4000 years. Ti, H. 2737 BC. NEI JING SU WEN HUANG TI (Yellow Emperor's Classic on Internal Medicine; referred to without citation in Small et al. 1975 Supra).
The taxonomy and nomenclature of the highly variable genus Cannabis (Emboden, W A, 29(3) ECONOMIC BOTANY 304-310 (1974)); (Small, E and Cronquist, A, 25(4) TAXON 405-435 (1976)); Small E and Cronquist, A 26(1) TAXON 110 (1977)); (Hillig, K W and Mahlberg, P G, 91(6) American Journal of Botany 966-975 (2004)), remains in question. This is in spite of the fact that its formal scientific name, ‘Cannabis sativa L.’, assigned by Carolus Linneaus (Linnaeus, C, 2 SPECIES PLANTARUM 1027 (1753), Salvius, Stockholm. Facsimile edition, 1957-1959. Ray Society, London, U.K.), is one of the oldest established names in botanical history and is still accepted to this day. Another species in the genus, ‘Cannabis indica Lam.’ was formally named somewhat later (de Lamarck, J B, 1(2) ENCYCLOPEDIE METHODIQUE DE BOTANIQUE, 694-5,(1785)), but is still very old in botanical history.
Three other species names were proposed in the 1800s to distinguish plants with presumably different characteristics (C. macrosperma Stokes, C. chinensis Delile, C gigantean Vilmorin), none of which are accepted today, although the epithet “indica” lives on as a subspecies of C. sativa (‘C. sativa ssp. indica Lam.’. Small and Cronquist 1976 Supra).
In the 20th century, two new names were added to the liturgy of proposed ‘Cannabis species: C. ruderalis’ Janischevsky and a hybrid, בC. intersita’ Sojak. Small, E, Jui, P Y, and Lefkovitch, L P, 1(1) SYSTEMATIC BOTANY 1(1): 67-84 (1976); Small and Cronquist 1976, Supra. Further, numerous names have been proposed for horticultural variants of ‘Cannabis’ but as of 1976, “very few of these have been validly published as formal taxa under the International Code of Botanical Nomenclature.” Small and Cronquist 1976 Supra. Moreover, other recent work continues to focus on higher-order evolutionary relationships of the genus. Cannabis has been variously ascribed as belonging to the mulberry family (Moraceae) (Engler, H G A, Ulmaceae, Moraceae and Urticaceae, pages 59-118 (1889) in: A. Engler and K. Prantl eds., DIE NATURLICHEN PFLANZENFAMILIEN 3(1). W. Engelmann, Leipzig, Germany; Judd, W S, Sanders, R W, and Donoghue, M J, 5 HARVARD PAPERS IN BOTANY 5: 1-51 (1994)); nettle family
(Urticaceae) (Berg, CC, Systematics and phylogeny of the Urticales, pages 193-220, in: P.R. Crane and S. Blackmore eds., EVOLUTION, SYSTEMATIC, AND FOSSIL HISTORY OF THE HAMAMELIDAE, VOL. 2, HIGHER HAMAMELIDAE, Clarendon Press, Oxford, U.K. (1989); Humpries, C J and Blackmore, S, A review of the classification of the Morcaceae, pages 267-277 In: Crane and Blackmore 1989 id.); and most recently in its own family with hops (Humulus), the Cannabaceae, or hemp family. Sytsma, K J, et al, 89(9) AMERICAN JOURNAL OF BOTANY 1531-1546 (2002).). While the work of Small and Cronquist 1976 Supra, seemed to effectively confine the genus to a single species with 2 subspecies (C. sativa s., C. s. indica), each with two varieties (C. s. s. var. sativa, C. s. s. var. spontanea; C. s. i. var. indica, C. s. i. var. Kafiristanica) largely on the basis of chemotaxonomy and interfertility of all forms, more recent work (Systma et al. 2002, Supra), proposes a two-species concept, resurrecting the binomial C. indica Lam. Since Sytsma et al. 2002 provides no key for discriminating between the species, the dichotomous key of Small and Cronquist 1976 Supra, which accounts for all forms in nature, whether wild or domesticated, was used to classify the characteristics of the plants described herein.
The objective of the breeding program which produced the novel plant of this invention was primarily to develop a plant having the following characteristics: (a) medicinal properties that included hypotensive activity; (b) psychoactive properties that motivated and energized, rather than creating lethargy, sleepiness, and increased food consumption.
The biologically active chemicals found in plants, phytochemicals, affect the normal structure or function of the human body and in some cases treat disease. The mechanisms for the medicinal and psychoactive properties of a cannabis plant, like any medicinal herb, are the pharmacologic effects of its phytochemicals and for a medical cannabis plant, the key phytochemicals are cannabinoids and terpenes. Tetrahydrocannabinol, THC, is the primary psychoactive and medicinal cannabinoid and is the result of the decarboxylation of tetrahydrocannabinolic acid (THC-A), its acidic precursor. THC-A, (6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6h-benzochromene-2-carboxylic acid, is found in the trichomes of the plant and converted into THC, which actually exists in only minute quantities in the living plant, after harvest and drying. Cannabigerol (CBG), Resorcinol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-, is not considered psychoactive, is known to block the psychoactive effects of THC. and is considered medically active in a variety of conditions. Its precursor, cannabigerolic acid, CBG-A, (E)-3-(3,7-Dimethyl-2,6-octadienyl)-2,4-dihydroxy-6-pentylbenzoic acid, is being studied medically. Cannabichromene, CBC, and cannabidiol, CBD, are both non-psychoactive and end products of CBG metaolism, like THC, that are used medically Cannabichromenic acid; CBC-A, 5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-7-pentyl-chromene-6-carboxylic acid, is acidic cannabichromene.
‘Equadorian Sativa’ has been shown by laboratory testing by Steephill Labs to contain cannabinoid CBG-A at 2.49 mg/g, tetrahydrocannibidiol THC-A at 139.46 mg/g, THC at 2.24 mg/g and cannabinoid CBC-A at 1.75 mg/g. ‘Equadorian Sativa’ cannabinoid content is dominated by its high content of THC (2.24 mg/g) and THC-A (139.46 mg/g).
Most varieties of high potency cannabis contain large quantities of three specific terpenes as well as various assortments of others. Those three terpenes are Beta-Myrcene, Beta Caryophyllene and Linalool. For instance, the variety CT3 has a profile with a high level of Beta-Myrcene, a moderate amount of Beta Caryophyllene and a small amount of Linalool, and a moderate amount of Limonene. ‘Equadorian Sativa’ has an unusual complement of terpenes. There are small levels of Beta Myrcene, Beta Caryophyllene and Linalool, but the Limonene level is extraordinarily high at a level of 4.53, 10 to 20 times the usual range. This sets ‘Equadorian Sativa’ apart from other varieties in its odor, the effects on mood and mentation and its medical qualities.
Physically, there are indications that its use may prevent some cancers and may cause apoptosis of cancer cells in vivo. There is a good possibility that the high levels of limonene may slow down the build-up of plaque in the arteries and reduce the effect of low-density lipo-proteins on the circulatory system. Indications are that ‘Equadorian Sativa’ has many medical qualities that make it an important tool to maintain health and deal with illness.
The inventor cultivated various strains of ‘Cannabis sativa’ in an effort to create a strain best suited to control his own disorder. This plant was derived from a female said to be of a strain called colloquially, ‘Celestial Temple Sativa’ an individual grown in Ecuador that reached a height of 23 ft (7 m), and was of the typical subspecies, ‘Cannabis sativa ssp. sativa’. The male parent is said to have been of a strain known colloquially as ‘island sweet skunk’ and reportedly to belonged to the subspecies ‘Cannabis sativa ssp. indica (Lam.)’. Small and Cronquist 1976 Supra. Neither ‘Celestial Temple Sativa’ nor ‘island sweet skunk’ has been patented in the United States or elsewhere, nor are they the subject of any pending patent applications of which the inventor is aware.
The particular plant disclosed herein was discovered in the area where the inventor was intentionally cross-pollinating and cultivating plants of cross between ‘Celestial Temple Sativa’ and ‘island sweet skunk’ described above using standard Mendelian breeding procedures well known to those of ordinary skill in the art. This resulted in the F1 generation of the inventor's cross, named ‘Pleadian’. It was in the proximity of plants of the ‘Pleadian’ variety that had become hermaphroditic, in the inventor's garden in Lake Tahoe Calif. that he discovered one female plant that could only be reproduced assexually, by taking cuttings and that plant is the origin of this remarkable new strain. The female plant was discovered in a section of the inventor's hydroponic garden. The plant has been and continues to be assexually reproduced by cutting at the inventor's garden in Lake Tahoe Calif.
Comparison of the Steephill Laboratory terpenoid/cannabinoid profiles of ‘Equadorian sativa’ with other plants with the same parents, ‘island sweet skunk’ and ‘Celestial Temple Sativa’ reveals that this plant, ‘Equadorian sativa’ has a phenotypically unique profile, particular insofar as its levels of limonene. Two plants with the same parents were known by the laboratory names of CTK and CT3 and ‘Equadorian sativa’ was tested by the laboratory name of CTA. Limonene found in ‘Equadorian sativa’, were 45.35 mg/g while CTK and CT3 were only 2.24 mg/g and 1.03 mg/g respectfully. ‘Equadorian sativa’ was shown to have substantially lower levels of cannabigerolic acid (CBG-A). cannabigerol (CBG) and Beta-Myrcene. ‘Equadorian sativa’ had levels of only 2.49 mg/g of CBG-A while CTK had 6.1 mg/g CBG-A and CT3 had 8.13 mg/g of CBG-A. ‘Equadorian sativa’ had only 0.001 mg/g of CBG while CTK had 0.3 mg/g CBG and CT3 had 0.54 mg/g of CBG. ‘Equadorian sativa’ had only 1.1 mg/g Beta-Myrcene while CTK had 12.01 mg/g Beta-Myrcene and CT3 had 11.44 mg/g Beta-Myrcene.
This data is presented in tabular form in Table 1.
TABLE 1 | |
Plant |
CTA | CTK | CT3 | |
Terpinoid or Cannabinoid | mg/g | mg/g | mg/g |
CBG-A | 2.49 | 6.1 | 8.31 |
CBG | 0.001 | 0.3 | 0.54 |
Beta Myrcene | 1.1 | 12.02 | 11.44 |
Limonene | 45.35 | 2.24 | 1.03 |
Asexual reproduction, colloqually known as “cloning” is a process well known to those of ordinary skill in the art of gardening and includes the following steps:
Step 1: From the female plant whose genetic profile is sought to be exactly reproduced, a 1″- 2″ cutting is taken;
Step 2: The cutting of the desired plant and is placed in a rooting solution that may be water, or a B1 vitamin that is generally the content of a rooting or cloning powder or gel;
Step 3: The cutting and rooting solution are placed into a rooting medium such as rock wool and RAPID ROOTER® a peat moss product available at hydroponics stores, gardening supply stores, and from many Internet merchants and must be water retaining so that the roots can take water up into the leaves;
Step 4: The cutting in rooting solution and rooting medium is placed under a humidity dome that may be an inverted plastic cup or is available in kits 1′-2′ long with a clear plastic dome to keep the humidity as high as possible to avoid the leaves drying before the cutting roots to insure viability;
Step 5: A a fluorescent light is placed just over the humidity dome that may be a generic work light available at hardware stores;
Step 6: One to two times a day, the humidity dome is removed for 30 seconds to insure the exchange of depleted air with fresh air to replenish the CO2.
Step 7: After maintaining this cutting in this manner, keeping the rooting medium wet at all times, for 5-14 days until root formation
Step 8: The rooted plants are maintained under flourescent high intensity lights in a soil-less medium, with standard hydroponic fertilizers, for 14 weeks;
The plant observed and identified in the photographs was cultivated in this manner at a temperature between 76 and 80 degrees Fahrenheit and was 14 weeks of age. The new plant differs from its parents and related cultivars in that it has energizing and motivating psychoactive effects as opposed to the lethargy normally associated with ssp. indica and the instant plant also shows hypotensive effects.
Step 4: The cutting in rooting solution and rooting medium is placed under a humidity dome that may be an inverted plastic cup or is available in kits 1′-2′ long with a clear plastic dome to keep the humidity as high as possible to avoid the leaves drying before the cutting roots to insure viability;
Step 5: A a fluorescent light is placed just over the humidity dome that may be a generic work light available at hardware stores;
Step 6: One to two times a day, the humidity dome is removed for 30 seconds to insure the exchange of depleted air with fresh air to replenish the CO2.
Step 7: After maintaining this cutting in this manner, keeping the rooting medium wet at all times, for 5-14 days until root formation
Step 8: The rooted plants are maintained under flourescent high intensity lights in a soil-less medium, with standard hydroponic fertilizers, for 14 weeks;
The plant observed and identified in the photographs was cultivated in this manner at a temperature between 76 and 80 degrees Fahrenheit and was 14 weeks of age. The new plant differs from its parents and related cultivars in that it has energizing and motivating psychoactive effects as opposed to the lethargy normally associated with ssp. indica and the instant plant also shows hypotensive effects.
Observation of the all female progeny of the original plant has demonstrated that this new and distinct variety has fulfilled the objectives and that its distinctive characteristics are firmly fixed and hold true from generation to generation vegetatively propagated from the original plant.
The accompanying photographs illustrate the overall appearance of the new ‘Equadorian sativa’ plants. These photographs show the colors as true as it is reasonably possible to obtain in reproductions of this type. Colors in the photographs may differ slightly from the color values cited in the detailed botanical description which accurately describe the colors of the new plant.
Sheet 1 ‘Cannabis CTS-A’ shows the flower of the ‘Equadorian sativa’ plant in the midst of leaves from above.
The photograph at the bottom of the Sheet 2, ‘Cannabis CTS-A’ comprises a close-up view of the flowering plant of ‘Equadorian sativa’;
Sheet 3, ‘Cannabis CTS-A’ comprises a slightly oblique and very close view of the ‘Equadorian sativa’.
The following is a detailed description of the new cultivar of ‘Equadorian sativa’.
- The plant:
-
- Type (life form and habit).—Herbaceous tap-rooted annual.
- Classification.—Cultivars of ‘Cannabis sativa’, possessing traits of the subspecies, ‘C. sativa ssp.. indica (Lam.)’ When navigating the key of Small and Cronquist, Id., the first couplet separates individuals based on their ability to intoxicate. This cultivated line possesses intoxicating properties, and so the subspecies sativa and its varieties (var. sativa and spontanea) are eliminated from consideration. Within the next couplet distinguishing within the subspecies indica, fruits are required to separate between the varieties (var. indica and var. kafiristanica). No fruits were found on any of the individuals observed, and so discrimination between the varieties is impossible with this key. Nevertheless, cross-section of the stem revealed that the stem is hollow, a characteristic known to occur with the fiber-producing strains of C. sativa ssp. sativa, and thought to be absent from the intoxicating taxa in the genus. As such, these plants appear to be hybrids of the two subspecies of ‘Cannabis sativa’, e.g., ‘C. sativa s.’ and ‘C. s. indica’.
-
- Origin, form, and growth characteristics:
-
- Origin.—Whole Plant Natural Mutation of the F1 cultivar Pleadian.
- Propagation.—The strain is perpetuated solely by cuttings.
- Mature habit.—Tap-rooted annual, with extensive fibrous root system, upright and much branched aerial portion of plant. The growth form of all cloned individuals seen (n=10) was highly manipulated by systematic removal of terminal buds, inducing a greater branching habit. Overall size in this form varies in the population from 1.6-1.9 m tall and 0.3-0.4 m across at their widest point. Many petiole scars on stems from systematic removal of large shade leaves. In this habit, these are obviously very vigorous annual herbs.
- Growth.—Very vigorous annuals herbs.
-
- Foliage: Leaves.
-
- Arrangement.—Alternate.
- Form.—Palmately compound, (3) 5-7 (9) linear-lanceolate leaflets with glandular hairs.
- Size.—Remaining (those still present when plants were observed) shade leaves, whole.
- Leaf (with petiole).—18-20 cm long; middle (largest) leaflet 10-12 cm long, 2.8 cm wide.
- Margins.—Coarsely serrate.
- Color.—Top — dark green, Pantone PMS 364.
- Color.—Bottom — light green, Pantone PMS 377.
- Veins, bottom.—Pronounced midrib, with straight axial branches at about 45° angle, toward distal end of leaflet.
- Color.—Light green, Pantone PMS 377.
- Petiole.—Length: 9-10 cm at maturity.
- Color.—Light green, Pantone PMS 377 as in the lower leaf surfaces.
- Stipules.—Sometimes present at base of petiole, 0.5 cm long, bulbous bases, acuminate (tapering concave to apex).
- Aroma.—Strongly mephitic, with hints of limonene, a cyclic terpene in Pinus ponderosa.
-
- Stem: Hollow, large, rugose, punctuate, minutely glandular, ribbed, with ribs running parallel to stem, 2.0-2.5 cm diameter at base.
-
- Color.—Bottom — light green, Pantone PMS 377. A few eglandular branched hairs.
- Height.—1.5-1.9 m at anthesis following heavy pruning regime in cultivation.
-
- Inflorescence:
-
- Blooming habit.—Elongated compound cymes or panicles, forming spikes from 0.3-0.5 m in length, densely packed with individual small pistillate flowers subtended by small leaves, these with densely packed capitate glandular trichomes.
-
- Flowers:
-
- Corolla.—Petals and calyx unified and collectively appressed to and surrounding the ovary.
- Color.—Light green, Pantone 372.
- Diameter.—Individual pistillate flowers 2-3 mm, cyme 5-10 cm diameter.
- Shape.—Urceolate (urn-shaped).
- Involucral bracts.—Absent, but two highly glandular, urceolate bracteoles enclose the flower.
- Calyces.—Appressed to the base of the ovary with the corolla as a unified perianth.
- Color.—Green, Pantone PMS 364.
- Filaments.—N/A — no staminate flowers observed.
- Stigma.—Length 5-7 mm, ca. 1 mm wide at base, tapering to distal end. Densely covered with minute (<1 mm) soft, straight hairs.
- Color.—Lemony white, Pantone PMS 372, drying slowly to red from apex to base after anthesis.
- Number.—2.
- Staminate column.—N/A — no staminate flowers observed.
- Fruit.—An achene in this genus; however, no fruits were seen as all pistillate flowers were sterile.
- Pollen.—N/A — no staminate flowers observed. Color: N/A — no staminate flowers observed.
- Petalage.—The plant is essentially without petals (apetalous); these fused and appressed to the base of the ovary with the calyx as the perianth.
-
- Flowers:
-
- Pedicel.—flowers are essentially sessile (attached directly to the stem), and as such have no pedicel. The color chart referenced is standard hexadecimal Web Pantone Color Chart well known to those of ordinary skill in Internet web site design.
-
- General characteristics and culture:
-
- Blooming period.—Cuttings after rooting will bloom in 9-11 weeks when <12 hrs light applied to induce flowering.
- Hardiness.—Probably fairly hardy; however, hardiness in nature unknown as this plant has only been cultivated in controlled conditions.
- Breaking action.—Stems are fibrous, strong, and flexible; highly resistant to breakage.
- Rooting.—>95% success rate with cuttings using CLONEX® a vitamin B1 rooting compound.
- Growth regulator.—No growth regulators or other hormones used in cultivation.
- Shipping tolerance.—Not applicable. This plant has never been shipped and is not intended for live shipment or household cultivation.
-
Claims (1)
1. A new and distinct cultivar of ‘Cannabis’ plant, as shown and described.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/661,271 USPP27475P2 (en) | 2010-03-13 | 2010-03-13 | Cannabis plant named ‘Ecuadorian Sativa’ |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/661,271 USPP27475P2 (en) | 2010-03-13 | 2010-03-13 | Cannabis plant named ‘Ecuadorian Sativa’ |
Publications (2)
Publication Number | Publication Date |
---|---|
US20160345477P1 US20160345477P1 (en) | 2016-11-24 |
USPP27475P2 true USPP27475P2 (en) | 2016-12-20 |
Family
ID=57322230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/661,271 Active 2032-04-30 USPP27475P2 (en) | 2010-03-13 | 2010-03-13 | Cannabis plant named ‘Ecuadorian Sativa’ |
Country Status (1)
Country | Link |
---|---|
US (1) | USPP27475P2 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10105343B2 (en) | 2010-04-30 | 2018-10-23 | Kubby Patent And Licenses, Limited Liability Company | Cannabis based compositions and methods of treating hypertension |
USPP30639P2 (en) * | 2018-05-10 | 2019-07-02 | CWB Holdings, Inc. | Hemp plant named ‘CW2A’ |
USPP31535P3 (en) | 2017-12-08 | 2020-03-10 | Biotech Institute LLC | Cannabis plant named ‘LEMON CRUSH OG’ |
US10624872B1 (en) | 2017-06-29 | 2020-04-21 | Charlotte's Web, Inc. | Apparatuses, methods, and systems for extraction, isolation and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith |
US10653085B1 (en) | 2018-12-21 | 2020-05-19 | Charlotte's Web, Inc. | Hemp plant named ‘CW1AS1’ |
US10777091B2 (en) | 2018-07-27 | 2020-09-15 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
US10878717B2 (en) | 2018-07-27 | 2020-12-29 | Joseph Pandolfino | Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes |
USPP32725P2 (en) | 2019-10-22 | 2021-01-05 | Biomax Seeds S.L. | Cannabis plant named ‘PAN2020’ |
US10888060B1 (en) | 2020-02-19 | 2021-01-12 | Charlotte's Web, Inc. | Hemp plant named ‘KIRSCHE’ |
USPP33483P3 (en) | 2018-11-28 | 2021-09-14 | Phytoplant Research S.L. | Cannabis plant named ‘Divina’ |
US11813833B2 (en) | 2019-12-09 | 2023-11-14 | Owens Corning Intellectual Capital, Llc | Fiberglass insulation product |
-
2010
- 2010-03-13 US US12/661,271 patent/USPP27475P2/en active Active
Non-Patent Citations (2)
Title |
---|
Forapani et al. Comparison of Hemp Varieties Using Random Amplified Polymorphic DNA Markers. Crop Science 41:1682-1689 (2001). * |
Recommended Methods for the Identification and Analysis of Cannabis and Cannabis Products.http://www.unodc.org/documents/scientific/ST-NAR-40-Ebook.pdf 2009. * |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10105343B2 (en) | 2010-04-30 | 2018-10-23 | Kubby Patent And Licenses, Limited Liability Company | Cannabis based compositions and methods of treating hypertension |
US11337954B2 (en) | 2017-06-29 | 2022-05-24 | Charlotte's Web, Inc. | Apparatuses, methods, and systems for extraction, isolation and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith |
US10849876B2 (en) | 2017-06-29 | 2020-12-01 | Charlotte's Web, Inc. | Apparatuses, methods and systems for extraction, isolation and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith |
US10624872B1 (en) | 2017-06-29 | 2020-04-21 | Charlotte's Web, Inc. | Apparatuses, methods, and systems for extraction, isolation and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith |
US10980773B2 (en) | 2017-06-29 | 2021-04-20 | Charlotte's Web, Inc. | Apparatuses, methods and systems for extraction, isolation and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith |
US11160781B2 (en) | 2017-06-29 | 2021-11-02 | Charlotte's Web, Inc. | Apparatuses, methods, and systems for extraction, isolation and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith |
USPP31707P3 (en) | 2017-12-08 | 2020-04-28 | Biotech Institute, Llc | Cannabis plant named ‘GRAPE LOLIPOP’ |
USPP31752P3 (en) | 2017-12-08 | 2020-05-12 | Biotech Institute, Llc | Cannabis plant named ‘cake batter cookies’ |
USPP31874P3 (en) | 2017-12-08 | 2020-06-16 | Biotech Institute, Llc | Cannabis plant named ‘HOLY CRUNCH’ |
USPP31918P3 (en) | 2017-12-08 | 2020-06-30 | Biotech Institute, Llc | Cannabis plant named ‘RAINBOW GUMMEEZ’ |
USPP31917P3 (en) | 2017-12-08 | 2020-06-30 | Biotech Institute, Llc | Cannabis plant named ‘RASPBERRY PUNCH’ |
USPP31724P3 (en) | 2017-12-08 | 2020-05-05 | Biotech Institute, Llc | Cannabis plant named ‘PRIMO CHERRY’ |
USPP31535P3 (en) | 2017-12-08 | 2020-03-10 | Biotech Institute LLC | Cannabis plant named ‘LEMON CRUSH OG’ |
USPP32473P3 (en) | 2017-12-08 | 2020-11-17 | Biotech Institute, Llc | Cannabis plant named ‘BIHEMP 050924’ |
USPP33000P3 (en) | 2017-12-08 | 2021-04-27 | Biotech Institute, Llc | Cannabis plant named ‘OG CITRON’ |
USPP30639P2 (en) * | 2018-05-10 | 2019-07-02 | CWB Holdings, Inc. | Hemp plant named ‘CW2A’ |
US10820624B2 (en) | 2018-07-27 | 2020-11-03 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
US10897925B2 (en) | 2018-07-27 | 2021-01-26 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
US10973255B2 (en) | 2018-07-27 | 2021-04-13 | Cabbacis Llc | Articles and formulations for smoking products and vaporizers |
US10878717B2 (en) | 2018-07-27 | 2020-12-29 | Joseph Pandolfino | Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes |
US11017689B2 (en) | 2018-07-27 | 2021-05-25 | Cabbacis Llc | Very low nicotine cigarette blended with very low THC cannabis |
US10777091B2 (en) | 2018-07-27 | 2020-09-15 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
USPP33483P3 (en) | 2018-11-28 | 2021-09-14 | Phytoplant Research S.L. | Cannabis plant named ‘Divina’ |
US10653085B1 (en) | 2018-12-21 | 2020-05-19 | Charlotte's Web, Inc. | Hemp plant named ‘CW1AS1’ |
USPP32725P2 (en) | 2019-10-22 | 2021-01-05 | Biomax Seeds S.L. | Cannabis plant named ‘PAN2020’ |
US11813833B2 (en) | 2019-12-09 | 2023-11-14 | Owens Corning Intellectual Capital, Llc | Fiberglass insulation product |
US10888060B1 (en) | 2020-02-19 | 2021-01-12 | Charlotte's Web, Inc. | Hemp plant named ‘KIRSCHE’ |
Also Published As
Publication number | Publication date |
---|---|
US20160345477P1 (en) | 2016-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USPP27475P2 (en) | Cannabis plant named ‘Ecuadorian Sativa’ | |
Sanders | The genera of Verbenaceae in the southeastern United States | |
US20200178447P1 (en) | Cannabis plant named 'EREZ' | |
USPP31707P3 (en) | Cannabis plant named ‘GRAPE LOLIPOP’ | |
US20160073568P1 (en) | Cannabis plant named 'MIDNIGHT' | |
USPP30639P2 (en) | Hemp plant named ‘CW2A’ | |
USPP34828P2 (en) | Hemp plant named ‘3 Crop’ | |
US11330778B2 (en) | Cannabis plant named ‘FS-tp2’ | |
USPP33332P3 (en) | Cannabis plant named ‘HAPPY PINEAPPLE’ | |
US20170172040P1 (en) | Cannabis plant named 'Katelyn Faith' | |
USPP17976P2 (en) | Sweetpotato plant named ‘Stokes purple’ | |
US20210136973P1 (en) | Hemp plant named 'Painted Lady' | |
Meghwal et al. | Lasoda or Gonda | |
USPP35668P3 (en) | Cannabis plant named ‘ZLT’ | |
USPP35689P3 (en) | Cannabis plant named ‘ZUCHI’ | |
USPP35667P3 (en) | Cannabis plant named ‘AFZ’ | |
USPP35691P3 (en) | Cannabis plant named ‘POI’ | |
USPP35690P3 (en) | Cannabis plant named ‘TZT’ | |
USPP35083P3 (en) | Cannabis plant named ‘Red KROSS02-BK’ | |
DE BOTANIQUE | Cannabis sativa ssp. indica (Lam.) | |
USPP35461P2 (en) | Astilbe plant named ‘Dark Side of the Moon’ | |
US20220256799A1 (en) | Cannabis plant named 'lpa004' | |
USPP32104P2 (en) | Echinacea plant named ‘Yellow My Darling’ | |
USPP10935P (en) | Mini plant Mentha arvensis `Himalaya` | |
Hernández-A et al. | Nelson R. Salinas, María F. González |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: KUBBY PATENT AND LICENSES, LIMITED LIABILITY COMPA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KUBBY, STEVEN WYNN;REEL/FRAME:032005/0126 Effective date: 20100513 |